Related references
Note: Only part of the references are listed.The kallikrein-kinin system in diabetic nephropathy
Hirofumi Tomita et al.
KIDNEY INTERNATIONAL (2012)
Altered Glucose Homeostasis and Hepatic Function in Obese Mice Deficient for Both Kinin Receptor Genes
Carlos C. Barros et al.
PLOS ONE (2012)
Insulin says NO to cardiovascular disease
Qiujun Yu et al.
CARDIOVASCULAR RESEARCH (2011)
Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing
Julie Chao et al.
BIOLOGICAL CHEMISTRY (2010)
Minireview: Update on Incretin Biology: Focus on Glucagon-Like Peptide-1
Patricia L. Brubaker
ENDOCRINOLOGY (2010)
Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARα/γ agonist on glycaemic control in Zucker diabetic fatty rats
C. L. Brand et al.
DIABETES OBESITY & METABOLISM (2009)
Tissue kallikrein elicits cardioprotection by direct kinin B2 receptor activation independent of kinin formation
Julie Chao et al.
HYPERTENSION (2008)
Tissue kallikrein reverses insulin resistance and attenuates nephropathy in diabetic rats by activation of phosphatidylinositol 3-kinase/protein kinase B and adenosine 5′-monophosphate-activated protein kinase signaling pathways
Gang Yuan et al.
ENDOCRINOLOGY (2007)
Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling
Paolo Madeddu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Bradykinin augments insulin-stimulated glucose transport in rat adipocytes via endothelial nitric oxide synthase-mediated inhibition of jun NH2-terminal kinase
Kristin M. Beard et al.
DIABETES (2006)
Kallikrein activates bradykinin B2 receptors in absence of kininogen
D Biyashev et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats
D Montanari et al.
DIABETES (2005)
The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity
J Damas et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)
GLP-1 derivative liraglutide in rats with β-cell deficiencies:: influence of metabolic state on β-cell mass dynamics
J Sturis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors
S Houle et al.
HYPERTENSION (2003)
Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats
CX Zhao et al.
HYPERTENSION (2003)
The kallikrein-kinin system in humans
DJ Campbell
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2001)
Bradyzide, a potent non-peptide B-2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia
GM Burgess et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
